Raymond James Financial’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.84M Sell
109,691
-120
-0.1% -$5.31K ﹤0.01% 2767
2026
Q2
$4.72M Buy
109,811
+2,375
+2% +$94.4K ﹤0.01% 2779
2026
Q1
$4.14M Buy
107,436
+1,769
+2% +$72.9K ﹤0.01% 2743
2025
Q4
$4.35M Buy
105,667
+1,463
+1% +$57.8K ﹤0.01% 2629
2025
Q3
$3.88M Buy
104,204
+7,069
+7% +$257K ﹤0.01% 2644
2025
Q2
$3.54M Buy
97,135
+8,023
+9% +$291K ﹤0.01% 2622
2025
Q1
$3.44M Buy
89,112
+3,428
+4% +$136K ﹤0.01% 2591
2024
Q4
$3.25M Buy
+85,684
New +$3.42M ﹤0.01% 2612

Other funds holding BME

Raymond James Financial's BME Position: Q3 2026 in Review

Raymond James Financial reduced its BlackRock Health Sciences Trust (BME) stake by 0.11% in Q3 2026, selling an estimated $5.31K and leaving 109,691 shares worth $4.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Raymond James Financial first reported a position in BME in Q4 2024 and has held it in 8 quarters since. 83 funds tracked by Wall St. Rank hold BME as of Q3 2026.

  • Raymond James Financial held 109,691 shares of BlackRock Health Sciences Trust worth $4.84M as of Q3 2026.
  • Raymond James Financial sold 120 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $5.31K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2767 holding.
  • Raymond James Financial first reported a position in BlackRock Health Sciences Trust in Q4 2024 and has held it in 8 quarters since.
  • 83 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.